FDA
approval
· 2020-08-11
FDA Approved: DICLOFENAC SODIUM — Supplemental Application (BluePoint Laboratories)
Summary
The FDA approved a supplemental application for diclofenac sodium topical gel, 1%, from BluePoint Laboratories. The action pertains to a generic product and sup…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM TOPICAL GEL, 1%)